+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

From
Pertussis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Pertussis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Pneumoconiosis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Pneumoconiosis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Pulmonary Fibrosis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Pulmonary Fibrosis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Cystic fibrosis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Cystic fibrosis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Ofev (Nintedanib) - Drug Insight and Market Forecast - 2030 - Product Thumbnail Image

Ofev (Nintedanib) - Drug Insight and Market Forecast - 2030

  • Report
  • August 2020
  • 80 Pages
  • Global
From
From
From
Research Report on China's Ceftriaxone Export 2023-2032 - Product Thumbnail Image

Research Report on China's Ceftriaxone Export 2023-2032

  • Report
  • January 2023
  • 50 Pages
  • China
From
Research Report on China's Gefitinib Market, 2021-2025 - Product Thumbnail Image

Research Report on China's Gefitinib Market, 2021-2025

  • Report
  • September 2021
  • 40 Pages
  • China
From
From
From
From
From
From
Investigation Report on China's Loratadine Market, 2018-2022 - Product Thumbnail Image

Investigation Report on China's Loratadine Market, 2018-2022

  • Report
  • December 2018
  • 30 Pages
  • China
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more